{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04086",
    "Peptide Name": "AA139 (synthetic AMPs20a, Arenicin-3 analog, 2S=S, UCSS1a; rAA139)",
    "Source": "animal derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GFCWYVCARRNGARVCYRRCN",
    "Sequence Length": 21,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 5,
    "Boman Index": 3.05,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "48%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (85.71%) toArenicin-3R: 24%; C: 19%.Activity: Active against E. coli (MIC 4.0 ug/ml), P. aeruginosa (MIC 2-16.0 ug/ml), K. pneumonia (MIC 8.0 ug/ml), A. baumannii (MIC 4 ug/ml), E. faecium (MIC 16.0 ug/ml), S. aureus (MIC 8.0 ug/ml), and C. acnes (MIC 63.0 ug/ml).Recombinant production:bacteria:Escherichia coli: BL21 (DE3) strain, SUMO fusion, recombinant AA139 (rAA139) at a yield 56 mg/L, purity: >98% (Zhang et al., 2024; cf.: other expression methods with yields: 0.8-9.7 mg/L).Updated 6/2024",
    "Author": "van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA, Kreft D, Ten Kate MT, Falciani C, Pini A, Strandh M, Bakker-Woudenberg IAJM, Hays JP, Goessens WHF. 2019",
    "Reference": "Int J Antimicrob Agents. 2019 Aug;54(2):159-166. doi: 10.1016/j.ijantimicag.2019.05.019.PubMed",
    "Title": "Antimicrobial activity of two novel antimicrobial peptides AA139 and SET-M33 against clinically and genotypically diverse Klebsiella pneumoniae isolates with differing antibiotic resistance profiles."
  },
  "3D Structure": []
}